Mustafa Özdoğan, MD· @ozdogan_md · X·· 1 天前评分70
正文 · 原文
SAFFRON: osimertinib + savolitinib vs platinum–pemetrexed in MET-driven EGFR-mutated NSCLC after osimertinib.
Open: ORR, CNS activity, crossover? #ESMO26
32 浏览 · 0 赞 · 0 转发 · 0 回复
来源：Mustafa Özdoğan, MD · x.com